Venetoclax in Chronic Lymphocytic Leukemia Effectiveness and Real-life Treatment Management
Venetoclax in Chronic Lymphocytic Leukemia Effectiveness and Real-life Treatment Management
This study will evaluate real-life effectiveness and use in participants starting venetoclax treatment for Chronic Lymphocytic Leukemia (CLL).
Inclusion Criteria:
Exclusion Criteria:
- Participating in a clinical trial with an investigative drug for CLL within 30 days prior to treatment initiation.
Besançon, Doubs 25000, France
Vandœuvre-lès-Nancy, Meurthe-et-Moselle 54511, France
Rouen, Seine-Maritime 76038, France
Epagny Metz Tessy, 74370, France
Monaco, 98000, France